series-a
Stage
2018
Founded
1
Investors
About
Anjarium Biosciences is a genetic medicine company developing a new generation of therapies. They utilize a proprietary platform with novel DNA-based gene vectors and a targeted delivery system to advance gene therapy and gene editing.
Explore Anjarium Biosciences AG's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.